Navigation Links
Panel Finds Evidence Murky on Full-Body Skin Exams

To detect cancer, people need to watch for lesions, experts stress

FRIDAY, Feb. 6 (HealthDay News) -- An examination of your entire body should not be the standard of care for finding skin cancer, a panel of experts has concluded.

"There is no new direct evidence on the benefits of screening for skin cancer with a whole-body exam by a physician or by self-exam," said Dr. Tracy Wolff, a medical officer at the U.S. Preventive Services Task Force, a program of the Agency for Healthcare Research and Quality, and lead researcher on the project.

The panel's report was published Feb. 3 in the Annals of Internal Medicine.

Wolff said that the task force, which reviewed published studies, could not find enough evidence to determine whether detecting skin cancer early reduces deaths from the disease.

It also concluded that information was limited about the ability of primary care doctors to perform adequate examinations in the context of usual care. "Therefore, the task force was unable to assess the balance of benefits and harms of screening for skin cancer by primary care physicians or by self-exam and gave this intervention an 'I' grade for insufficient evidence," Wolff said.

As a result, the panel did not change the stance in guidelines put out in 2001 that says insufficient evidence exists to recommend for or against routine screening for melanoma, basal cell or squamous cell skin cancer using a total-body skin examination, Wolff said.

"Until there is better evidence to say for sure whether screening in the general public is beneficial, primary care clinicians and patients should remain alert for skin lesions that are worrisome for cancer," she said.

Dr. Jeffrey C. Salomon, an assistant clinical professor of plastic surgery at Yale University School of Medicine, said that being aware of lesions on your skin is important in finding skin cancer.

"Skin cancers can masquerade as benign-appearing lesions," Salomon said. "In any patient with a prior history of skin cancer, I recommend that they self-examine on a regular basis."

If they develop a skin lesion that does not resolve within six weeks, he said, the lesion should be medically evaluated.

"Surveillance can identify obvious malignant lesions," Salomon said. "But for many lesions, surgical biopsy will be required to definitively determine if a lesion is benign or malignant. I cannot rely solely on my clinical exam for pathologic diagnosis."

"Every month I see lesions that I thought were benign and on biopsy were malignant, and vice versa," he said.

There is no substitute, he said, for a close relationship with a dermatopathologist, a specialist in diagnosing skin biopsies, when dealing with skin lesions. "While most skin cancers have low morbidity and low mortality risks, early diagnosis makes treatment easier, and early biopsy can give both patient and physician peace of mind," Salomon said.

More information

The American Cancer Society has more on skin cancer.

Checking Your Skin

Wondering how to know whether something on your skin is cancerous? Dr. Tracy Wolff, a medical officer at the U.S. Preventive Services Task Force, a program of the Agency for Healthcare Research and Quality, says to simply follow the ABCD rule:

  • A = asymmetry of lesion
  • B = border of lesion is irregular
  • C = color is variable
  • D = diameter is larger than a pencil eraser (more than 6 millimeters)

Any skin lesions with these characteristics or any lesion that is changing should be brought to the attention of your doctor for further examination and possible biopsy, Wolff says.

SOURCES: Tracy Wolff, M.D., M.P.H., medical officer, U.S. Preventive Services Task Force, Agency for Healthcare Research and Quality, Rockville, Md.; Jeffrey C. Salomon, M.D., assistant clinical professor, plastic surgery, Yale University School of Medicine, New Haven, Conn.; Feb. 3, 2009, Annals of Internal Medicine

Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Virginia Tech Review Panel Calls For Reform of Mental Health Treatment Law
2. CryoCor Invited to Participate in FDA Advisory Panel Meeting on Atrial Fibrillation
3. Patient Safety Authority Board of Directors Names Infection Advisory Panel
4. Partners Rx Chief Pharmacy Officer, Richard Bullard on Panel Discussion at the Fall 2007 Managed Markets Summit (MMS) in Phoenix, AZ.
5. Billians HealthDATA GM Speaking on Dreamforce 07 Panel
6. FDA Panel Recommends Approval of SyntheMeds REPEL-CV(R) Adhesion Barrier for Pediatric Patients
7. Abaxis Announces New Waived Kidney Check Panel Exclusively for Imaging and Radiology Centers
8. Health Courts Critic to be Featured Speaker at Wyoming Patient Safety Panel
9. FDA Panel Mulls Ban on Kids Cold Medicines
10. FDA Panel Weighs Ban on Kids Cold Medicines
11. FDA Panel Recommends Ban on Cold Medicines for Kids
Post Your Comments:
Related Image:
Panel Finds Evidence Murky on Full-Body Skin Exams 
(Date:11/25/2015)... ... , ... “While riding the bus, I saw a passenger in a wheelchair ... to be a convenient and comfortable way to protect them from bad weather, so ... safely travel during cold or inclement weather. In doing so, it ensures that the ...
(Date:11/25/2015)... ... 2015 , ... Privately owned Contract Development and Manufacturing Organization ... current state of the art research, development and manufacturing facility outside of Fort ... capacity as well as to support its clients’ growing research and development and ...
(Date:11/25/2015)... ... , ... Students and parents have something to be thankful for this Thanksgiving ... awards. California Casualty is proud to support the contest designed to utilize ... driving, the number one killer of young drivers. , Almost 1,000 entries of ...
(Date:11/24/2015)... ... , ... New patients who wish to seek treatment for missing teeth can ... her Mississauga, ON practice. Dr. Williams has been providing dental service for over 34 ... Missing teeth can lead to a variety of complications if they are not replaced ...
(Date:11/24/2015)... , ... November 25, 2015 , ... ... and development solutions for drugs, biologics, consumer health and global clinical supply services, ... at the upcoming Clinical Trial Supply East Asia Conference, to be held at ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... and VANCOUVER, Nov. 24, 2015 /PRNewswire/ - ESSA Pharma Inc. ... ) announced today that the first patient has been ... as a treatment for metastatic castration-resistant prostate cancer ("mCRPC"). ... Canada.  --> the United States ... the Phase 1/2 clinical trial, ESSA intends to demonstrate ...
(Date:11/24/2015)... PUNE, India , November 24, 2015 ... new market research report "Spine Biologics Market by Product Type ... Type (Anterior Cervical Discectomy and Fusion, Posterior Lumbar Interbody Fusion), ... by MarketsandMarkets, the global market was valued at $1.90 Billion ... 2020, at a CAGR of 4.4% during the forecast period ...
(Date:11/24/2015)... India , November 24, 2015 ... . --> adds Latest Guidebook ... report of 217 pages published in November 2015 ... its online business intelligence library at ... one of the fastest growing global economies with ...
Breaking Medicine Technology: